Profile
Alfred E.
Slanetz is the founder of Geneius Biotechnology, Inc. founded in 2014, where he holds the titles of President, Chief Executive Officer & Director.
He is currently a Director at Aim-Hi Accelerator Fund, Inc. Dr. Slanetz's former positions include President & Chief Executive Officer at bluebird bio, Inc., Head-New Product Planning at Genentech, Inc., and Vice President-Business Development at Transgene SA. Dr. Slanetz's education includes a graduate degree from Brown University, an undergraduate degree from Hamilton College (New York), and a doctorate degree from Yale University.
Alfred E. Slanetz active positions
| Companies | Position | Start |
|---|---|---|
Geneius Biotechnology, Inc.
Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops autologous and adoptive cell therapy technology | Founder | 2014-12-31 |
Aim-Hi Accelerator Fund, Inc.
Aim-Hi Accelerator Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that supports startup oncology companies | Director/Board Member | - |
Former positions of Alfred E. Slanetz
| Companies | Position | End |
|---|---|---|
| TRANSGENE | Corporate Officer/Principal | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| GENETIX BIOTHERAPEUTICS, INC. | President | - |
Training of Alfred E. Slanetz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Geneius Biotechnology, Inc.
Geneius Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Develops autologous and adoptive cell therapy technology | Commercial Services |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hamilton College (New York)
Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aim-Hi Accelerator Fund, Inc.
Aim-Hi Accelerator Fund, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that supports startup oncology companies | Commercial Services |
- Stock Market
- Insiders
- Alfred E. Slanetz
















